Jazz Pharmaceuticals plc — Director's Dealing 2016

Mar 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2016-02-29

Reporting Person: Treacy Paul (SVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-29	Ordinary Shares	S	352.0	$123.48	Disposed	15102	Direct
2016-02-29	Ordinary Shares	S	2.0	$123.4725	Disposed	15100	Direct

Footnotes

F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.